Folic acid functionalized surface highlights 5-methylcytosine-genomic content within circulating tumor cells

Natalia Malara, Maria Laura Coluccio, Tania Limongi, Monica Asande, Valentina Trunzo, Gheorghe Cojoc, Cinzia Raso, Patrizio Candeloro, Gerardo Perozziello, Raffaella Raimondo, Stefania De Vitis, Laura Roveda, Maria Renne, Ubaldo Prati, Vincenzo Mollace, Enzo Di Fabrizio

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Although the detection of methylated cell free DNA represents one of the most promising approaches for relapse risk assessment in cancer patients, the low concentration of cell-free circulating DNA constitutes the biggest obstacle in the development of DNA methylation-based biomarkers from blood. This paper describes a method for the measurement of genomic methylation content directly on circulating tumor cells (CTC), which could be used to deceive the aforementioned problem. Since CTC are disease related blood-based biomarkers, they result essential to monitor tumor's stadiation, therapy, and early relapsing lesions. Within surface's bio-functionalization and cell's isolation procedure standardization, the presented approach reveals a singular ability to detect high 5-methylcytosine CTC-subset content in the whole CTC compound, by choosing folic acid (FA) as transducer molecule. Sensitivity and specificity, calculated for FA functionalized surface (FA-surface), result respectively on about 83% and 60%. FA-surface, allowing the detection and characterization of early metastatic dissemination, provides a unique advance in the comprehension of tumors progression and dissemination confirming the presence of CTC and its association with high risk of relapse. This functionalized surface identifying and quantifying high 5-methylcytosine CTC-subset content into the patient's blood lead significant progress in cancer risk assessment, also providing a novel therapeutic strategy.

Original languageEnglish
Pages (from-to)4324-4331
Number of pages8
JournalSmall
Volume10
Issue number21
DOIs
Publication statusPublished - Nov 12 2014

Fingerprint

5-Methylcytosine
Circulating Neoplastic Cells
Folic Acid
Tumors
Cells
Acids
Blood
Neoplasms
Biomarkers
Risk assessment
Recurrence
Aptitude
DNA
Hematologic Diseases
Cell Separation
DNA Methylation
Transducers
Methylation
Standardization
Sensitivity and Specificity

Keywords

  • folic acid
  • folic acid receptors
  • functionalized surfaces
  • hyper-methylated circulating tumor cells

ASJC Scopus subject areas

  • Biomaterials
  • Engineering (miscellaneous)
  • Biotechnology
  • Medicine(all)

Cite this

Malara, N., Coluccio, M. L., Limongi, T., Asande, M., Trunzo, V., Cojoc, G., ... Di Fabrizio, E. (2014). Folic acid functionalized surface highlights 5-methylcytosine-genomic content within circulating tumor cells. Small, 10(21), 4324-4331. https://doi.org/10.1002/smll.201400498

Folic acid functionalized surface highlights 5-methylcytosine-genomic content within circulating tumor cells. / Malara, Natalia; Coluccio, Maria Laura; Limongi, Tania; Asande, Monica; Trunzo, Valentina; Cojoc, Gheorghe; Raso, Cinzia; Candeloro, Patrizio; Perozziello, Gerardo; Raimondo, Raffaella; De Vitis, Stefania; Roveda, Laura; Renne, Maria; Prati, Ubaldo; Mollace, Vincenzo; Di Fabrizio, Enzo.

In: Small, Vol. 10, No. 21, 12.11.2014, p. 4324-4331.

Research output: Contribution to journalArticle

Malara, N, Coluccio, ML, Limongi, T, Asande, M, Trunzo, V, Cojoc, G, Raso, C, Candeloro, P, Perozziello, G, Raimondo, R, De Vitis, S, Roveda, L, Renne, M, Prati, U, Mollace, V & Di Fabrizio, E 2014, 'Folic acid functionalized surface highlights 5-methylcytosine-genomic content within circulating tumor cells', Small, vol. 10, no. 21, pp. 4324-4331. https://doi.org/10.1002/smll.201400498
Malara N, Coluccio ML, Limongi T, Asande M, Trunzo V, Cojoc G et al. Folic acid functionalized surface highlights 5-methylcytosine-genomic content within circulating tumor cells. Small. 2014 Nov 12;10(21):4324-4331. https://doi.org/10.1002/smll.201400498
Malara, Natalia ; Coluccio, Maria Laura ; Limongi, Tania ; Asande, Monica ; Trunzo, Valentina ; Cojoc, Gheorghe ; Raso, Cinzia ; Candeloro, Patrizio ; Perozziello, Gerardo ; Raimondo, Raffaella ; De Vitis, Stefania ; Roveda, Laura ; Renne, Maria ; Prati, Ubaldo ; Mollace, Vincenzo ; Di Fabrizio, Enzo. / Folic acid functionalized surface highlights 5-methylcytosine-genomic content within circulating tumor cells. In: Small. 2014 ; Vol. 10, No. 21. pp. 4324-4331.
@article{1e1b158b939f450b8e43481e44b295d5,
title = "Folic acid functionalized surface highlights 5-methylcytosine-genomic content within circulating tumor cells",
abstract = "Although the detection of methylated cell free DNA represents one of the most promising approaches for relapse risk assessment in cancer patients, the low concentration of cell-free circulating DNA constitutes the biggest obstacle in the development of DNA methylation-based biomarkers from blood. This paper describes a method for the measurement of genomic methylation content directly on circulating tumor cells (CTC), which could be used to deceive the aforementioned problem. Since CTC are disease related blood-based biomarkers, they result essential to monitor tumor's stadiation, therapy, and early relapsing lesions. Within surface's bio-functionalization and cell's isolation procedure standardization, the presented approach reveals a singular ability to detect high 5-methylcytosine CTC-subset content in the whole CTC compound, by choosing folic acid (FA) as transducer molecule. Sensitivity and specificity, calculated for FA functionalized surface (FA-surface), result respectively on about 83{\%} and 60{\%}. FA-surface, allowing the detection and characterization of early metastatic dissemination, provides a unique advance in the comprehension of tumors progression and dissemination confirming the presence of CTC and its association with high risk of relapse. This functionalized surface identifying and quantifying high 5-methylcytosine CTC-subset content into the patient's blood lead significant progress in cancer risk assessment, also providing a novel therapeutic strategy.",
keywords = "folic acid, folic acid receptors, functionalized surfaces, hyper-methylated circulating tumor cells",
author = "Natalia Malara and Coluccio, {Maria Laura} and Tania Limongi and Monica Asande and Valentina Trunzo and Gheorghe Cojoc and Cinzia Raso and Patrizio Candeloro and Gerardo Perozziello and Raffaella Raimondo and {De Vitis}, Stefania and Laura Roveda and Maria Renne and Ubaldo Prati and Vincenzo Mollace and {Di Fabrizio}, Enzo",
year = "2014",
month = "11",
day = "12",
doi = "10.1002/smll.201400498",
language = "English",
volume = "10",
pages = "4324--4331",
journal = "Small",
issn = "1613-6810",
publisher = "Wiley-VCH Verlag",
number = "21",

}

TY - JOUR

T1 - Folic acid functionalized surface highlights 5-methylcytosine-genomic content within circulating tumor cells

AU - Malara, Natalia

AU - Coluccio, Maria Laura

AU - Limongi, Tania

AU - Asande, Monica

AU - Trunzo, Valentina

AU - Cojoc, Gheorghe

AU - Raso, Cinzia

AU - Candeloro, Patrizio

AU - Perozziello, Gerardo

AU - Raimondo, Raffaella

AU - De Vitis, Stefania

AU - Roveda, Laura

AU - Renne, Maria

AU - Prati, Ubaldo

AU - Mollace, Vincenzo

AU - Di Fabrizio, Enzo

PY - 2014/11/12

Y1 - 2014/11/12

N2 - Although the detection of methylated cell free DNA represents one of the most promising approaches for relapse risk assessment in cancer patients, the low concentration of cell-free circulating DNA constitutes the biggest obstacle in the development of DNA methylation-based biomarkers from blood. This paper describes a method for the measurement of genomic methylation content directly on circulating tumor cells (CTC), which could be used to deceive the aforementioned problem. Since CTC are disease related blood-based biomarkers, they result essential to monitor tumor's stadiation, therapy, and early relapsing lesions. Within surface's bio-functionalization and cell's isolation procedure standardization, the presented approach reveals a singular ability to detect high 5-methylcytosine CTC-subset content in the whole CTC compound, by choosing folic acid (FA) as transducer molecule. Sensitivity and specificity, calculated for FA functionalized surface (FA-surface), result respectively on about 83% and 60%. FA-surface, allowing the detection and characterization of early metastatic dissemination, provides a unique advance in the comprehension of tumors progression and dissemination confirming the presence of CTC and its association with high risk of relapse. This functionalized surface identifying and quantifying high 5-methylcytosine CTC-subset content into the patient's blood lead significant progress in cancer risk assessment, also providing a novel therapeutic strategy.

AB - Although the detection of methylated cell free DNA represents one of the most promising approaches for relapse risk assessment in cancer patients, the low concentration of cell-free circulating DNA constitutes the biggest obstacle in the development of DNA methylation-based biomarkers from blood. This paper describes a method for the measurement of genomic methylation content directly on circulating tumor cells (CTC), which could be used to deceive the aforementioned problem. Since CTC are disease related blood-based biomarkers, they result essential to monitor tumor's stadiation, therapy, and early relapsing lesions. Within surface's bio-functionalization and cell's isolation procedure standardization, the presented approach reveals a singular ability to detect high 5-methylcytosine CTC-subset content in the whole CTC compound, by choosing folic acid (FA) as transducer molecule. Sensitivity and specificity, calculated for FA functionalized surface (FA-surface), result respectively on about 83% and 60%. FA-surface, allowing the detection and characterization of early metastatic dissemination, provides a unique advance in the comprehension of tumors progression and dissemination confirming the presence of CTC and its association with high risk of relapse. This functionalized surface identifying and quantifying high 5-methylcytosine CTC-subset content into the patient's blood lead significant progress in cancer risk assessment, also providing a novel therapeutic strategy.

KW - folic acid

KW - folic acid receptors

KW - functionalized surfaces

KW - hyper-methylated circulating tumor cells

UR - http://www.scopus.com/inward/record.url?scp=84928940938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928940938&partnerID=8YFLogxK

U2 - 10.1002/smll.201400498

DO - 10.1002/smll.201400498

M3 - Article

C2 - 25044603

AN - SCOPUS:84928940938

VL - 10

SP - 4324

EP - 4331

JO - Small

JF - Small

SN - 1613-6810

IS - 21

ER -